机构:[1]Cell Biological Therapy Center of Kunming General Hospital, Chengdu Military Area Command of PLA, Cell Biological Medicine Integrated Engineering Laboratory of State and Region, Kunming, Yunnan Province, People’s Republic of China[2]Cardiovascular Institute of Xinqiao Hospital, Third Military Medical University, Chongqing, People’s Republic of China[3]Department of Clinical Laboratory, PLA Kunming General Hospital Clinical College of Medicine, Kunming Medical University, Kunming, Yunnan Province, People’s Republic of China
The dysfunction of endothelial progenitor cells (EPCs) was found to be associated with vascular complications in diabetes mellitus (DM) patients. Previous studies found that regular exercise could improve the function of EPCs in DM patients, but the underling mechanism was unclear. Irisin, a newly identified myokine, was induced by exercise and has been demonstrated to mediate some of the positive effects of exercise. In this study, we hypothesize that irisin may have direct effects on EPC function in DM mice. These data showed for the first time that irisin increased the number of EPCs in peripheral blood of DM mice and improved the function of EPCs derived from DM mice bone marrow. The mechanism for the effect of irisin is related to the PI3K/Akt/eNOS pathway. Furthermore, irisin was demonstrated to improve endothelial repair in DM mice that received EPC transplants after carotid artery injury. The results of this study indicate a novel effect of irisin in regulating the number and function of EPCs via the PI3K/Akt/eNOS pathway, suggesting a potential for the administration of exogenous irisin as a succedaneum to improve EPC function in diabetic patients who fail to achieve such improvements through regular exercise.
基金:
National Natural Science Foundation of China
(81170316).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类|3 区医学
小类|3 区药学4 区心脏和心血管系统
最新[2023]版:
大类|4 区医学
小类|4 区心脏和心血管系统4 区药学
第一作者:
第一作者机构:[1]Cell Biological Therapy Center of Kunming General Hospital, Chengdu Military Area Command of PLA, Cell Biological Medicine Integrated Engineering Laboratory of State and Region, Kunming, Yunnan Province, People’s Republic of China[*1]Cell Biological Therapy Center of Kunming General Hospital, Chengdu Military Area Command of PLA, Cell Biological Medicine Integrated Engineering Laboratory of State and Region, Daguan Road No. 212, Xishan District of Kunming, Kunming 650032, Yunnan Province, People’s Republic of China
共同第一作者:
通讯作者:
通讯机构:[1]Cell Biological Therapy Center of Kunming General Hospital, Chengdu Military Area Command of PLA, Cell Biological Medicine Integrated Engineering Laboratory of State and Region, Kunming, Yunnan Province, People’s Republic of China[*1]Cell Biological Therapy Center of Kunming General Hospital, Chengdu Military Area Command of PLA, Cell Biological Medicine Integrated Engineering Laboratory of State and Region, Daguan Road No. 212, Xishan District of Kunming, Kunming 650032, Yunnan Province, People’s Republic of China
推荐引用方式(GB/T 7714):
Zhu Guangxu,Wang Jinxiang,Song Mingbao,et al.Irisin Increased the Number and Improved the Function of Endothelial Progenitor Cells in Diabetes Mellitus Mice.[J].Journal of cardiovascular pharmacology.2016,68(1):67-73.doi:10.1097/FJC.0000000000000386.
APA:
Zhu Guangxu,Wang Jinxiang,Song Mingbao,Zhou Fang,Fu Dagan...&Pan Xinghua.(2016).Irisin Increased the Number and Improved the Function of Endothelial Progenitor Cells in Diabetes Mellitus Mice..Journal of cardiovascular pharmacology,68,(1)
MLA:
Zhu Guangxu,et al."Irisin Increased the Number and Improved the Function of Endothelial Progenitor Cells in Diabetes Mellitus Mice.".Journal of cardiovascular pharmacology 68..1(2016):67-73